Pain and its treatment in outpatients with metastatic cancer.

PubWeight™: 9.54‹?› | Rank: Top 0.1%

🔗 View Article (PMID 7508092)

Published in N Engl J Med on March 03, 1994

Authors

C S Cleeland1, R Gonin, A K Hatfield, J H Edmonson, R H Blum, J A Stewart, K J Pandya

Author Affiliations

1: Pain Research Group, Department of Neurology, Madison, WI 53705-4013.

Articles citing this

(truncated to the top 100)

Prevalence of undertreatment in cancer pain. A review of published literature. Ann Oncol (2008) 4.70

Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer. J Clin Oncol (2012) 3.65

Optimized antidepressant therapy and pain self-management in primary care patients with depression and musculoskeletal pain: a randomized controlled trial. JAMA (2009) 3.56

Guidelines for managing chronic non-malignant pain. Opioids and other agents. College of Physicians and Surgeons of Alberta. Can Fam Physician (1995) 3.45

The epidemiology of pain during the last 2 years of life. Ann Intern Med (2010) 2.62

Clinical characteristics of veterans prescribed high doses of opioid medications for chronic non-cancer pain. Pain (2010) 2.44

Deletion of vanilloid receptor 1-expressing primary afferent neurons for pain control. J Clin Invest (2004) 2.28

A cross-sectional study on prevalence of pain and breakthrough pain among an unselected group of outpatients in a tertiary cancer clinic. Support Care Cancer (2014) 1.97

Effect of telecare management on pain and depression in patients with cancer: a randomized trial. JAMA (2010) 1.95

Symptom clusters in cancer patients with bone metastases. Support Care Cancer (2007) 1.89

Diffusion of standards of care for cancer pain. CMAJ (1995) 1.86

Multicentre study of cancer pain and its treatment in France. BMJ (1995) 1.78

A Wireless Health Outcomes Monitoring System (WHOMS): development and field testing with cancer patients using mobile phones. BMC Med Inform Decis Mak (2004) 1.72

Comparison of prospective and retrospective indicators of the quality of end-of-life cancer care. J Clin Oncol (2008) 1.70

Patient training in cancer pain management using integrated print and video materials: a multisite randomized controlled trial. Pain (2008) 1.69

Do gender and race affect decisions about pain management? J Gen Intern Med (2001) 1.68

Somatic symptom reporting in women and men. J Gen Intern Med (2001) 1.67

Magnetic resonance-guided focused ultrasound for patients with painful bone metastases: phase III trial results. J Natl Cancer Inst (2014) 1.66

New therapeutic options for lysosomal storage disorders: enzyme replacement, small molecules and gene therapy. Hum Genet (2006) 1.65

A strategy to advance the evidence base in palliative medicine: formation of a palliative care research cooperative group. J Palliat Med (2010) 1.64

A primary care, multi-disciplinary disease management program for opioid-treated patients with chronic non-cancer pain and a high burden of psychiatric comorbidity. BMC Health Serv Res (2005) 1.58

Acute pain management for patients receiving maintenance methadone or buprenorphine therapy. Ann Intern Med (2006) 1.56

Pain management in nursing home residents with cancer. J Am Geriatr Soc (2015) 1.49

Management of specific symptom complexes in patients receiving palliative care. CMAJ (1998) 1.48

Quality of end-of-life cancer care in Canada: a retrospective four-province study using administrative health care data. Curr Oncol (2015) 1.44

Randomized controlled trial of standardized education and telemonitoring for pain in outpatients with advanced solid tumors. Support Care Cancer (2013) 1.42

Translational approaches to treatment-induced symptoms in cancer patients. Nat Rev Clin Oncol (2012) 1.38

Pattern and quality of care of cancer pain management. Results from the Cancer Pain Outcome Research Study Group. Br J Cancer (2009) 1.37

Quality of life of 5-10 year breast cancer survivors diagnosed between age 40 and 49. Health Qual Life Outcomes (2004) 1.36

The quality of emergency department pain care for older adult patients. J Am Geriatr Soc (2010) 1.36

Health care providers underestimate symptom intensities of cancer patients: a multicenter European study. Health Qual Life Outcomes (2010) 1.34

Pain assessment and treatment disparities: a virtual human technology investigation. Pain (2009) 1.31

Gene therapy for pain: results of a phase I clinical trial. Ann Neurol (2011) 1.31

Image-guided ablation of painful metastatic bone tumors: a new and effective approach to a difficult problem. Skeletal Radiol (2005) 1.30

The symptom burden of cancer: Evidence for a core set of cancer-related and treatment-related symptoms from the Eastern Cooperative Oncology Group Symptom Outcomes and Practice Patterns study. Cancer (2013) 1.30

Emergency department crowding and decreased quality of pain care. Acad Emerg Med (2008) 1.28

Pain, depression, and fatigue in community-dwelling adults with and without a history of cancer. J Pain Symptom Manage (2006) 1.25

Somatic symptoms in patients with cancer experiencing pain or depression: prevalence, disability, and health care use. Arch Intern Med (2010) 1.22

Neuropathic and nociceptive pain in head and neck cancer patients receiving radiation therapy. Head Neck Oncol (2009) 1.22

Prevalence and management of pain in Italian patients with advanced non-small-cell lung cancer. Br J Cancer (2004) 1.20

Vanilloids in pancreatic cancer: potential for chemotherapy and pain management. Gut (2005) 1.20

Gender and ethnic differences in cancer pain experience: a multiethnic survey in the United States. Nurs Res (2007) 1.16

Identifying potential need for cancer palliation in Nova Scotia. CMAJ (1998) 1.15

Racial differences in opioid use for chronic nonmalignant pain. J Gen Intern Med (2005) 1.14

Barriers and facilitators to chronic pain self-management: a qualitative study of primary care patients with comorbid musculoskeletal pain and depression. Pain Med (2009) 1.13

The association of depression and pain with health-related quality of life, disability, and health care use in cancer patients. J Pain Symptom Manage (2010) 1.12

Defining racial and ethnic disparities in pain management. Clin Orthop Relat Res (2011) 1.12

Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid. Support Care Cancer (2013) 1.12

Evaluation of nurses' self-insight into their pain assessment and treatment decisions. J Pain (2009) 1.12

Adherence to clinical guidelines for opioid therapy for chronic pain in patients with substance use disorder. J Gen Intern Med (2011) 1.11

Levels of symptom burden during chemotherapy for advanced lung cancer: differences between public hospitals and a tertiary cancer center. J Clin Oncol (2011) 1.11

The WHO analgesic ladder for cancer pain control, twenty years of use. How much pain relief does one get from using it? Support Care Cancer (2006) 1.08

Clinicians' practice and attitudes toward cancer pain management in Korea. Support Care Cancer (2006) 1.07

Virtual human technology: patient demographics and healthcare training factors in pain observation and treatment recommendations. J Pain Res (2010) 1.07

Ethnic differences in pain and pain management. Pain Manag (2012) 1.06

Treating patients with fibromyalgia in primary care settings under routine medical practice: a claim database cost and burden of illness study. Arthritis Res Ther (2009) 1.05

Neural correlates of chronic low back pain measured by arterial spin labeling. Anesthesiology (2011) 1.05

Edmonton Regional Palliative Care Program: impact on patterns of terminal cancer care. CMAJ (1999) 1.05

Self-efficacy for coping with cancer in a multiethnic sample of breast cancer patients: associations with barriers to pain management and distress. Clin J Pain (2010) 1.05

Burden of post-herpetic neuralgia in a sample of UK residents aged 50 years or older: findings from the Zoster Quality of Life (ZQOL) study. Health Qual Life Outcomes (2014) 1.04

The Indiana Cancer Pain and Depression (INCPAD) trial Design of a telecare management intervention for cancer-related symptoms and baseline characteristics of study participants. Gen Hosp Psychiatry (2009) 1.04

Barriers to pain management in a community sample of Chinese American patients with cancer. J Pain Symptom Manage (2008) 1.03

Impact of cultural and linguistic factors on symptom reporting by patients with cancer. J Natl Cancer Inst (2010) 1.03

Experience of pain among women with advanced HIV disease. AIDS Patient Care STDS (2009) 1.02

Psychopathology predicts the outcome of medial branch blocks with corticosteroid for chronic axial low back or cervical pain: a prospective cohort study. BMC Musculoskelet Disord (2009) 1.02

Anxiety, depression, and pain: differences by primary cancer. Support Care Cancer (2009) 1.01

The effect of comorbidity burden on health care utilization for patients with cancer using hospice. J Palliat Med (2011) 1.01

Efficacy of an intervention for fatigue and sleep disturbance during cancer chemotherapy. J Pain Symptom Manage (2010) 0.99

The Impact of Massage Therapy on Function in Pain Populations-A Systematic Review and Meta-Analysis of Randomized Controlled Trials: Part II, Cancer Pain Populations. Pain Med (2016) 0.99

Pain and emotional well-being outcomes in Southwest Oncology Group-directed intergroup trial S0205: a phase III study comparing gemcitabine plus cetuximab versus gemcitabine as first-line therapy in patients with advanced pancreas cancer. J Clin Oncol (2010) 0.99

Assessing persistent cancer pain: a comparison of current pain ratings and pain recalled from the past week. J Pain Symptom Manage (2008) 0.99

Validation of brief pain inventory to Brazilian patients with pain. Support Care Cancer (2010) 0.98

Preliminary report of a palliative care and case management project in an emergency department for chronically ill elderly patients. J Urban Health (2008) 0.98

The perception of pain in others: how gender, race, and age influence pain expectations. J Pain (2012) 0.98

The use of a responder analysis to identify differences in patient outcomes following a self-care intervention to improve cancer pain management. Pain (2007) 0.98

Cancer-related and treatment-related fatigue. Gynecol Oncol (2014) 0.98

Effects of coaching patients with lung cancer to report cancer pain. West J Nurs Res (2010) 0.97

Individual difference variables and the effects of progressive muscle relaxation and analgesic imagery interventions on cancer pain. J Pain Symptom Manage (2008) 0.97

Validation of the M. D. Anderson Symptom Inventory multiple myeloma module. J Hematol Oncol (2013) 0.96

Percutaneous ablation for bone and soft tissue metastases--why cryoablation? Skeletal Radiol (2009) 0.95

The impact of patients' gender, race, and age on health care professionals' pain management decisions: an online survey using virtual human technology. Int J Nurs Stud (2013) 0.95

Patient-reported outcome measures for systemic lupus erythematosus clinical trials: a review of content validity, face validity and psychometric performance. Health Qual Life Outcomes (2014) 0.95

Bone-targeting radiopharmaceuticals for the treatment of prostate cancer with bone metastases. Cancer Lett (2012) 0.95

Pain and its treatment in hospitalized patients with metastatic cancer. Support Care Cancer (2003) 0.95

The cancer pain experience of Israeli adults 65 years and older: the influence of pain interference, symptom severity, and knowledge and attitudes on pain and pain control. Support Care Cancer (2005) 0.95

Achievement of personalized pain goal in cancer patients referred to a supportive care clinic at a comprehensive cancer center. Cancer (2011) 0.94

Barriers to cancer pain management: home-health and hospice nurses and patients. Support Care Cancer (2003) 0.94

Bioethics for clinicians: 15. Quality end-of-life care. CMAJ (1998) 0.94

Hospice, opiates, and acute care service use among the elderly before death from heart failure or cancer. Am Heart J (2010) 0.94

[What is the profile of palliative care in Germany. Results of a representative survey]. Schmerz (2004) 0.93

Management of chronic pain in the elderly: focus on transdermal buprenorphine. Clin Interv Aging (2008) 0.93

Pain in cancer. An outcome research project to evaluate the epidemiology, the quality and the effects of pain treatment in cancer patients. Health Qual Life Outcomes (2006) 0.93

Treating cancer pain. N Engl J Med (1994) 0.93

Craving of prescription opioids in patients with chronic pain: a longitudinal outcomes trial. J Pain (2012) 0.93

Palliative care in primary care: a study to determine whether patients and professionals agree on symptoms. Br J Gen Pract (2006) 0.93

Sex differences in the risk of receiving potentially inappropriate prescriptions among older adults. Age Ageing (2016) 0.92

The impact of the palliative care mobile team on symptom assessment and medication profiles in patients admitted to a comprehensive cancer center. Support Care Cancer (2006) 0.91

A validation study of the WHO analgesic ladder: a two-step vs three-step strategy. Support Care Cancer (2005) 0.91

Pain assessment: the cornerstone to optimal pain management. Proc (Bayl Univ Med Cent) (2000) 0.91

A population-based study of pain and quality of life during the year before death in men with prostate cancer. Br J Cancer (2004) 0.91

Articles by these authors

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol (1996) 9.68

Rubella hemagglutinin prepared with alkaline extraction of virus grown in suspension culture of BHK-21 cells. Proc Soc Exp Biol Med (1967) 5.61

Langerhans cell histiocytosis: diagnosis, natural history, management, and outcome. Cancer (1999) 4.65

High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190. J Clin Oncol (2000) 4.60

Prior herpes simplex virus type 2 infection as a risk factor for HIV infection. JAMA (1988) 3.89

Measles antibody: reevaluation of protective titers. J Infect Dis (1990) 3.77

Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists. Hum Pathol (1996) 3.59

Pain and treatment of pain in minority patients with cancer. The Eastern Cooperative Oncology Group Minority Outpatient Pain Study. Ann Intern Med (1997) 3.48

Isolation and identification of Haemophilus ducreyi in a clinical study. J Clin Microbiol (1980) 3.40

Physician attitudes and practice in cancer pain management. A survey from the Eastern Cooperative Oncology Group. Ann Intern Med (1993) 3.25

Rubella hemagglutinin prepared in serum free suspension culture of BHK-21 cells. Ann Med Exp Biol Fenn (1967) 2.89

Adriamycin. A new anticancer drug with significant clinical activity. Ann Intern Med (1974) 2.77

A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses. Neurology (2006) 2.75

Megestrol acetate for the prevention of hot flashes. N Engl J Med (1994) 2.72

A clinical review of bleomycin--a new antineoplastic agent. Cancer (1973) 2.53

The microbiological flora of penile ulcerations. J Infect Dis (1978) 2.43

Indirect hemagglutination test for detection of antibodies to Cytomegalovirus. Appl Microbiol (1971) 2.28

Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas. J Clin Oncol (1993) 2.28

A randomized trial of adding insulin glargine vs. avoidance of insulin in people with Type 2 diabetes on either no oral glucose-lowering agents or submaximal doses of metformin and/or sulphonylureas. The Canadian INSIGHT (Implementing New Strategies with Insulin Glargine for Hyperglycaemia Treatment) Study. Diabet Med (2006) 2.15

Cyclophosphamide plus cis-platinum in combination: treatment program for stage III or IV ovarian carcinoma. Obstet Gynecol (1982) 2.12

Additive efficacy of unoprostone isopropyl 0.12% (rescula) to latanoprost 0.005%. Am J Ophthalmol (2001) 2.06

Multidisciplinary approach to deep-seated lesions requiring radiologically-guided fine-needle aspiration. Diagn Cytopathol (1998) 2.04

Cytomegalovirus specific IgM and IgG response in humans studied by radioimmunoassay. J Immunol (1976) 2.03

Phase III trial of dacarbazine versus dacarbazine with interferon alpha-2b versus dacarbazine with tamoxifen versus dacarbazine with interferon alpha-2b and tamoxifen in patients with metastatic malignant melanoma: an Eastern Cooperative Oncology Group study. J Clin Oncol (1998) 1.94

Late relapse of testicular cancer. J Clin Oncol (1995) 1.87

Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects on cytomegalovirus and herpes simplex virus infections. N Engl J Med (1979) 1.83

Reliability testing of the dermatology index of disease severity (DIDS). An index for staging the severity of cutaneous inflammatory disease. Arch Dermatol (1997) 1.81

Cytomegalovirus pneumonia after human marrow transplantation. Ann Intern Med (1975) 1.80

Fundamental dilemmas of the randomized clinical trial process: results of a survey of the 1,737 Eastern Cooperative Oncology Group investigators. J Clin Oncol (1994) 1.79

A cluster of patients with a chronic mononucleosis-like syndrome. Is Epstein-Barr virus the cause? JAMA (1987) 1.75

Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor. J Clin Oncol (1998) 1.72

Method for typing antisera to Herpesvirus hominis by indirect hemagglutination inhibition. Appl Microbiol (1971) 1.70

How reliable is the morphological diagnosis of penile ulcerations? Sex Transm Dis (1978) 1.70

Randomized clinical trial of diethylstilbestrol versus tamoxifen in postmenopausal women with advanced breast cancer. N Engl J Med (1981) 1.70

Evaluation of monoclonal antibody-based capture enzyme immunoassays for detection of specific antibodies to measles virus. J Clin Microbiol (1991) 1.68

Prognostic factors predictive of survival and local recurrence for extremity soft tissue sarcoma. Ann Surg (1994) 1.65

Spontaneous cytomegalovirus mononucleosis. Clinical and laboratory observations in nine cases. Ann Intern Med (1973) 1.65

Phase II trial of docetaxel (Taxotere) in patients with adenocarcinoma of the upper gastrointestinal tract previously untreated with cytotoxic chemotherapy: the Eastern Cooperative Oncology Group (ECOG) results of protocol E1293. Med Oncol (1996) 1.65

The role of radiotherapy in the management of operable locally advanced breast carcinoma: results of a randomized trial by the Eastern Cooperative Oncology Group. Cancer (1997) 1.60

Surveillance for congenital cytomegalovirus disease: a report from the National Congenital Cytomegalovirus Disease Registry. Clin Infect Dis (1995) 1.60

Combined doppler and phased-array echocardiographic estimation of cardiac output. Circulation (1981) 1.57

Untreated 24-h intraocular pressures measured with Goldmann applanation tonometry vs nighttime supine pressures with Perkins applanation tonometry. Eye (Lond) (2009) 1.57

Experimental alveolar lipo-proteinosis following the inhalation of silica. J Pathol (1970) 1.56

Prevalence of measles antibodies in asymptomatic human immunodeficiency virus-infected adults. J Infect Dis (1991) 1.50

Rubella complement fixing antigen prepared by alkaline extraction of virus grown in suspension culture of BHK-211 cells. Proc Soc Exp Biol Med (1967) 1.49

The pancreas in recent-onset type 1 (insulin-dependent) diabetes mellitus: insulin content of islets, insulitis and associated changes in the exocrine acinar tissue. Diabetologia (1984) 1.48

Doctors who do not feel sober enough to drive should avoid helping in medical emergencies. BMJ (1998) 1.47

Collagen content of alveolar wall tissue in emphysematous and non-emphysematous lungs. Thorax (1994) 1.46

Varicella zoster virus is a cause of the acute retinal necrosis syndrome. Ophthalmology (1986) 1.43

Cost-effectiveness of latanoprost and timolol maleate for the treatment of glaucoma in Scandinavia and the United Kingdom, using a decision-analytic health economic model. Eye (Lond) (2007) 1.43

Detection of persistent left superior vena cava by two-dimensional contrast echocardiography. J Clin Ultrasound (1979) 1.42

Prognostic value of histologic grade and proliferative activity in axillary node-positive breast cancer: results from the Eastern Cooperative Oncology Group Companion Study, EST 4189. J Clin Oncol (2000) 1.42

Prevalence of acne keloidalis nuchae in football players. J Am Acad Dermatol (1997) 1.41

Mammography after treatment for breast cancer. BMJ (1994) 1.40

Defining new standards for adjuvant therapy of testis cancer. J Clin Oncol (1995) 1.39

Cerebrovascular risk factors and stroke subtypes: differences between ethnic groups. Stroke (2001) 1.39

Linitis plastica caused by metastatic lobular carcinoma of the breast. Mayo Clin Proc (1980) 1.39

Beyond code teams: early defibrillation by nurses for in-hospital cardiac arrests. J Emerg Nurs (1992) 1.39

Dosimetry of swallowed non absorbed 99mTc radiopharmaceuticals in pediatric patients. Eur J Nucl Med (1990) 1.39

Optimizing "delay period" for burst stimulation in dynamic cardiomyoplasty. Ann Thorac Surg (1995) 1.38

Effect of breathing on the detection of in vivo simulated pulmonary nodules by spiral CT. Clin Radiol (1998) 1.38

Phase I-II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas. Gene Ther (2005) 1.36

Comparison of antibody concentrations and protective activity of respiratory syncytial virus immune globulin and conventional immune globulin. J Infect Dis (1994) 1.34

Pulmonary resection for metastatic nonosteogenic sarcoma. Cancer (1979) 1.34

Echocardiographic documentation of vegetative lesions in infective endocarditis: clinical implications. Circulation (1980) 1.32

Cytomegalovirus mononucleosis in a first trimester pregnant female with transmission to the fetus. Pediatrics (1971) 1.31

The relationship of acute transfusion-associated hepatitis to the development of cirrhosis in the presence of alcohol abuse. Ann Intern Med (2001) 1.30

Evaluation of serological techniques for titration of rubella antibody. Am J Public Health Nations Health (1969) 1.29

Protective activity of a human respiratory syncytial virus immune globulin prepared from donors screened by microneutralization assay. J Infect Dis (1992) 1.27

Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials. Advanced Ovarian Cancer Trialists' Group. Br J Cancer (1998) 1.27

The clinical validity of the treatment satisfaction survey for intraocular pressure in ocular hypertensive and glaucoma patients. Eye (Lond) (2006) 1.26

Prediction of node-negative breast cancer outcome by histologic grading and S-phase analysis by flow cytometry: an Eastern Cooperative Oncology Group Study (2192). Am J Clin Oncol (2001) 1.26

Trends and variability in survival from osteosarcoma. Mayo Clin Proc (1978) 1.26

Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group. J Clin Oncol (1989) 1.25

Mapping and serodiagnostic application of a dominant epitope within the human herpesvirus 8 ORF 65-encoded protein. J Clin Microbiol (1998) 1.25

Surveillance for chronic fatigue syndrome--four U.S. cities, September 1989 through August 1993. MMWR CDC Surveill Summ (1997) 1.25

Primary cytomegalovirus and opportunistic infections. Incidence in renal transplant recipients. JAMA (1978) 1.24

Identification of a nucleocapsid protein as a specific serological marker of human herpesvirus 6 infection. J Clin Microbiol (1990) 1.23

Multicenter comparison of PCR assays for detection of human herpesvirus 8 DNA in semen. J Clin Microbiol (1999) 1.22

How well is the Patient Self-Determination Act working?: an early assessment. Am J Med (1993) 1.21

Interferon-inducible protein 10 and macrophage inflammatory protein-1 alpha inhibit growth factor stimulation of Raf-1 kinase activity and protein synthesis in a human growth factor-dependent hematopoietic cell line. J Biol Chem (1995) 1.20

Predicting the risk of bacteremia in childen with fever and neutropenia. J Clin Oncol (1996) 1.20

Twenty four hour heart rate variability: effects of posture, sleep, and time of day in healthy controls and comparison with bedside tests of autonomic function in diabetic patients. Br Heart J (1991) 1.20

Etoposide, doxorubicin, and cisplatin chemotherapy for advanced gastric adenocarcinoma: results of a phase II trial. J Clin Oncol (1992) 1.19

A randomized multicenter study of remifentanil compared with halothane in neonates and infants undergoing pyloromyotomy. I. Emergence and recovery profiles. Anesth Analg (2001) 1.19

Multimodality therapy for malignant mesothelioma based on a study of natural history. Am J Med (1980) 1.19

Complete responses and long-term survivals after systemic chemotherapy for patients with advanced malignant melanoma. Cancer (1989) 1.18

Rubella antibody persistence after immunization. Sixteen-year follow-up in the Hawaiian Islands. JAMA (1988) 1.18

Guidelines for the prevention and treatment of B-virus infections in exposed persons. The B virus Working Group. Clin Infect Dis (1995) 1.18

Immune responses associated with chronic fatigue syndrome: a case-control study. J Infect Dis (1997) 1.17

Effect of low-dose interleukin-2 on disease relapse after T-cell-depleted allogeneic bone marrow transplantation. Blood (1994) 1.17

A retrospective study of earliest indicators of recurrence in patients on Eastern Cooperative Oncology Group adjuvant chemotherapy trials for breast cancer. A preliminary report. Cancer (1985) 1.16

National case-control study of Kaposi's sarcoma and Pneumocystis carinii pneumonia in homosexual men: Part 2. Laboratory results. Ann Intern Med (1983) 1.16

Cyclophosphamide pharmacokinetics: correlation with cardiac toxicity and tumor response. J Clin Oncol (1992) 1.15

Idiopathic acute fatty liver of pregnancy. Death from extrahepatic manifestations. Am J Dig Dis (1972) 1.14

Plasmablastic morphology--an independent prognostic factor with clinical and laboratory correlates: Eastern Cooperative Oncology Group (ECOG) myeloma trial E9486 report by the ECOG Myeloma Laboratory Group. Blood (1998) 1.14

A simple stratification factor prognostic for survival in advanced cancer: the good/bad/uncertain index. J Clin Oncol (2001) 1.12